A collection of advocacy groups have come together to challenge a series of conferences being offered in India on pharma intellectual property issues. The conferences, which are backed by drugmakers, law firms and the George Washington University Law School, are part of an effort known as the India Project. While the discussions are billed as neutral forums, the groups claim that the effort does more to protect U.S. IP interests than offer balanced academic discussions. Report